| 11 |
Value of FoxO3a Gene Expression in Pediatric Acute Lymphoblastic Leukemia |
2023 |
| 12 |
Association of follicular helper T and follicular regulatory T cells with severity and hyperglycemia in hospitalized COVID-19 patients |
2022 |
| 13 |
Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells |
2022 |
| 14 |
Could Argyrophilic Nucleolar Organizer Regions count mirror DNA Ploidy in Malignant Salivary Gland Tumors? |
2022 |
| 15 |
Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia |
2022 |
| 16 |
Genetic variation in FOXP3 and ROR‑γ genes in pediatric acute lymphocytic leukemia (ALL) patients: correlation with associated cytokines |
2022 |
| 17 |
Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer |
2022 |
| 18 |
Prognostic outcome of mesenchymal transition biomarkers in correlation with EGFR expression in epithelial ovarian carcinoma patients |
2022 |
| 19 |
Regulatory T-lymphocyte subsets in children with chronic immune thrombocytopenia after high-dose of dexamethasone |
2022 |
| 20 |
Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2 |
2022 |
